I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Leave site
Roche and Genentech at

AAO 2025

We will be contributing to topics related to
-
08:00 AM
Duration 10hrs Orlando, USA
Robust Vision Gain and Anatomic Improvement With Faricimab▼ in Patients With PCV: Week 48 Results From SALWEEN
Gemmy Cheung, Timothy Y. Y. Lai, Shih-Jen Chen, Tomohiro Iida, Adrian Koh, Junyeop Lee, Won Ki Lee, Xiaorong Li, Paisan Ruamviboonsuk, Xiaodong Sun, Yasuo Yanagi, Ruobing Bai, Anh Nguyen Duc, Philippe Margaron
Duration 10hrs Orlando, USA
Comparative Efficacy of Faricimab▼ for DME at Years 1 and 2: Systematic Literature Review and Network Meta-Analysis
Mark Barakat, Jakob Siedlecki, Christian Buehrer, Oliver Cox, Kara Gibson, Nancy Holekamp, Florie Mar
Duration 10hrs Orlando, USA
Improved Vascular Stability Biomarkers With Faricimab▼ vs Aflibercept Using Automated Quantification on UWFA, CFP and OCT
Murtaza Adam, Justis Ehlers, Andreas Pollreisz, Prethy Rao, Colin Tan, Gavin Tan, Thomas Albrecht, Manuel Amador, Fethallah Benmansou, Florie Mar, Dawn Sim, Ming Yang, Kara Gibson
12:36 PM
Duration 7mins Orlando
RHONE-X Extension Study: Clinical Improvements in Eyes With DME Switched From Aflibercept to Faricimab▼
Nathan Steinle, Roger Goldberg, Ian Pearce, Veeral Sheth, Arshad Khanani, Cheryl Jones, Kara Gibson, Timothy Lai, Patricio Schlottmann, Dawn Sim
08:20 PM
Duration 7mins Orlando
Efficacy and Safety of Vamikibart in Patients With Uveitic Macular Edema: First Report of Phase 3 MEERKAT/SANDCAT Trials
Rahul Khurana (TBC), Carlos Pavesio, Nisha Acharya, Koh-hei Sonoda & Eric Suhler (first and last author on manuscript). Steeples L, Brittain C , Fauser S, Galloway D, Haskova Z, Macgregor L, Mesquida M, Silverman D
Coming soon